Susan Hoffman
Internal Medicine · Palo Alto, CANPI 1457401317
Payments from drug & device makers
Across 330 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- Novo Nordisk$967
- AbbVie$935
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$542
- GSK$272
- Lilly USA, LLC$249
- plus $2K from 29 others
What the payments were for
- Food & beverage$6,337100%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 68 | $1,290 |
| Novo Nordisk | 60 | $967 |
| AbbVie(2 entities) | 48 | $935 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $542 |
| GSK | 12 | $272 |
| Lilly USA, LLC | 13 | $249 |
| Radius Health, Inc. | 7 | $215 |
| CMP Pharma, Inc. | 10 | $210 |
| Exact Sciences | 6 | $139 |
| Sanofi Pasteur Inc. | 6 | $135 |
| Merck | 7 | $131 |
| Novartis | 5 | $116 |
| E.r. Squibb & Sons, L.L.C. | 5 | $105 |
| Esperion Therapeutics, Inc. | 4 | $99 |
| Teva Pharmaceuticals USA, Inc. | 4 | $98 |
| Boehringer Ingelheim | 5 | $81 |
| Amgen | 3 | $79 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Sumitomo Pharma America, Inc. | 3 | $69 |
| Nabriva Therapeutics, PLC | 4 | $65 |
| AstraZeneca | 3 | $61 |
| Johnson & Johnson | 3 | $51 |
| Currax Pharmaceuticals LLC | 3 | $50 |
| Sunovion Pharmaceuticals Inc. | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $41 |
| Abbott | 2 | $39 |
| Therapeuticsmd, Inc. | 2 | $33 |
| Hologic Sales And Service, LLC | 1 | $29 |
| Shield Therapeutics Inc | 1 | $29 |
| Baxter Healthcare | 1 | $26 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Indivior Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Dova Pharmaceuticals | 1 | $15 |
How this compares
$6,357 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 67 | $86,648 |
| EliquisApixaban | 60 | $48,674 |
| MounjaroTirzepatide | 36 | $36,669 |
| JanuviaSitagliptin Phosphate | 14 | $6,326 |
| Testosterone | 12 | $5,346 |
| PaxlovidNirmatrelvir/Ritonavir | 28 | $4,288 |
| Celecoxib | 41 | $2,917 |
| Estradiol | 25 | $2,875 |
| Potassium Chloride | 34 | $2,093 |
| Levothyroxine Sodium | 189 | $2,028 |
| SynthroidLevothyroxine Sodium | 26 | $1,786 |
| Zolpidem Tartrate | 100 | $1,743 |
| Rosuvastatin Calcium | 63 | $1,681 |
| Hydroxyzine Hcl | 11 | $1,532 |
| Valsartan | 61 | $1,349 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $967 | $86,64867 claims |
| PfizerEliquis, Paxlovid | $1,290 | $52,96288 claims |
| Lilly USA, LLCMounjaro | $249 | $36,66936 claims |
| MerckJanuvia | $131 | $6,32614 claims |
| AbbVieSynthroid | $935 | $1,78626 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Palo Alto
- Andrew ChengSouth San Francisco$55.1M
- Joel NeutelTustin$34.9M
- Donald BrandonSan Diego$34M
- William TownerLos Angeles$27.4M
- Rahul AggarwalSan Francisco$24M
- Masoud AzizadNorthridge$21.1M
- Helen StaceyWalnut Creek$20.4M
- Rohit Loombala Jolla$15.1M
- Zeid KayaliColton$14.2M
- Alexandra DrakakiSanta Monica$14.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.